Top compounds associated with response to FSHR


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
mRNA PF-4800567 hydrochloride CTRPv2 pan-cancer AAC -0.055 0.3
mRNA GSK2636771 CTRPv2 pan-cancer AAC -0.043 0.3
mRNA 968 CTRPv2 pan-cancer AAC -0.068 0.3
mRNA PHA-665752 CCLE pan-cancer AAC 0.045 0.3
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.05 0.3
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.032 0.3
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.035 0.3
mRNA NSC23766 CTRPv2 pan-cancer AAC 0.034 0.3
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
Download CSV